Abstract:Background Toll-like receptors (TLRs) are important components of the innate and adaptive immune systems, and abnormal TLR expression has been linked to a variety of cancers. However, there was a lack of clarity on the association of TLR stimulation with the carcinogenesis of cancer. The study's goal was to analyse the clinical importance of TLRs expression at the mRNA level in pan-cancer datasets, as well as the link between TLR expression and carcinogenesis, progression, and clinical prognosis.Methods The expression profile of TLRs derived from UCSC pan-cancer data was analysed in multiple dimensions, including clinical analysis, immunological subtype analysis, tumour microenvironment (TME) analysis, tumour stem cell correlation analysis, and drug sensitivity analysis. Additionally, we analyse protein-protein interactions, functional enrichment, and chromatin accessibility, as well as TLR expression in single-cell sequencing data.Results Our multi-omics analysis results imply that TLRs may operate as a biological marker for carcinogenesis and progression, a potential target for anti-tumour therapy, and a prognostic biomarker, laying the theoretical groundwork for future translational medicine research.Conclusion TLRs are involved in the formation of malignancies and can be explored in further detail as potential prognostic indicators. Key MessagesToll-like receptors (TLRs) are key factors in the process of the innate and adaptive immune response, and their aberrant expression of TLRs have been widely reported in various cancer. However, the association between TLRs stimulation and tumorigenesis of cancer has not been well clarified.In this study, in the pan-cancer data, integrated TLR family gene expression analysis, clinical correlation analysis, immune subtype correlation analysis, tumour microenvironment correlation analysis, tumour stem cell correlation analysis, and drug sensitivity correlation analysis were performed.TLRs play an important role in the development of tumours and can be studied in depth as potential prognostic markers.

Progress in Effects of UNC93B1 on TLR Signaling Pathways and Its Relationship with Pathogenesis

Toll-like Receptor 3 and Tumor Immunity

The Effects of Microrna-34A Regulating Notch-1/NF-κB Signaling Pathway on Lipopolysaccharide-Induced Human Umbilical Vein Endothelial Cells.

A novel UNC93B1 gain-of-function mutation leads to TLR7 and TLR8 hyperactivation and systemic lupus erythematosus

UNCovering new causes of monogenic systemic lupus erythematosus

UNC93B1 Is Widely Expressed in the Murine CNS and Is Required for Neuroinflammation and Neuronal Injury Induced by MicroRNA let-7b

[Progress on Mechanisms for Pathogensto Evade NOD-like Receptor and Toll-like Receptor Signaling Pathways].

UNC93B1 variants underlie TLR7-dependent autoimmunity

Genetic variants in UNC93B1 predispose to childhood-onset systemic lupus erythematosus

The Role of Toll-Like Receptors (tlrs) in Pan-Cancer

IRF3 Prevents Colorectal Tumorigenesis Via Inhibiting the Nuclear Translocation of Β-Catenin.

Enhanced TLR-induced NF-κB Signaling and Type I Interferon Responses in NLRC5 Deficient Mice

Effect of TLR3 and TLR7 activation in uterine NK cells from non-obese diabetic (NOD) mice.

Defective endomembrane dynamics in Rab27a deficiency impairs nucleic acid sensing and cytokine secretion in immune cells

Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

Role and significance of lymphotoxin α1/β2 and its receptor LTβR in intestinal mucosal immunity of ulcerative colitis

Regulation of TRIF-mediated innate immune response by K27-linked polyubiquitination and deubiquitination

Effect of TLR4 and B7-H1 on immune escape of urothelial bladder cancer and its clinical significance.

HBD-3 Regulation of the Immune Response and the LPS/TLR4-mediated Signaling Pathway

Two rare UNC93B1 variants contribute to childhood-onset lupus

E3 ubiquitin ligase CBLB regulates innate immune responses and bacterial dissemination during nontuberculous mycobacteria infection